13F HOLDINGS REPORT (Amended)
SECTOR GAMMA AS
Quarter ended Q1 2023 · Filed February 8, 2023 · Accession 0001567619-23-002025
Total Value
$437.4M
Positions
31
Other Managers
0
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 596,036 | $51.2M | 11.70% |
| 2 | INCYTE CORP | INCY | 411,487 | $33.1M | 7.56% |
| 3 | CARDINAL HEALTH INC | CAH | 353,872 | $27.2M | 6.22% |
| 4 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 377,669 | $27.2M | 6.21% |
| 5 | ELEVANCE HEALTH INC | ELV | 47,777 | $24.5M | 5.60% |
| 6 | MERCK & CO INC | MRK | 199,300 | $22.1M | 5.06% |
| 7 | MEDTRONIC PLC | MDT | 277,435 | $21.6M | 4.93% |
| 8 | ZIMMER BIOMET HOLDINGS INC | ZBH | 154,116 | $19.6M | 4.49% |
| 9 | BIOGEN INC | BIIB | 70,039 | $19.4M | 4.43% |
| 10 | LABORATORY CORP AMER HLDGS | 50540R409 | 74,496 | $17.5M | 4.01% |
| 11 | BIOMARIN PHARMACEUTICAL INC | BMRN | 155,009 | $16.0M | 3.67% |
| 12 | CENTENE CORP DEL | CNC | 184,901 | $15.2M | 3.47% |
| 13 | SEAGEN INC | SE | 106,207 | $13.6M | 3.12% |
| 14 | BOSTON SCIENTIFIC CORP | BSX | 294,784 | $13.6M | 3.12% |
| 15 | BRUKER CORP | BRKRP | 191,982 | $13.1M | 3.00% |
| 16 | EDWARDS LIFESCIENCES CORP | EW | 174,252 | $13.0M | 2.97% |
| 17 | QIAGEN NV | QGEN | 233,473 | $11.6M | 2.66% |
| 18 | BAXTER INTL INC | 071813109 | 221,088 | $11.3M | 2.58% |
| 19 | ILLUMINA INC | ILMN | 47,500 | $9.6M | 2.20% |
| 20 | TENET HEALTHCARE CORP | THC | 195,954 | $9.6M | 2.19% |
| 21 | CIGNA CORP NEW | 125523100 | 22,252 | $7.4M | 1.69% |
| 22 | NUVASIVE INC | NU | 173,842 | $7.2M | 1.64% |
| 23 | BIO RAD LABS INC | 090572207 | 15,988 | $6.7M | 1.54% |
| 24 | IONIS PHARMACEUTICALS INC | IONS | 141,373 | $5.3M | 1.22% |
| 25 | CVS HEALTH CORP | CVS | 43,443 | $4.0M | 0.93% |
| 26 | BIONTECH SE | BNTX | 23,738 | $3.6M | 0.82% |
| 27 | PTC THERAPEUTICS INC | PTCT | 86,692 | $3.3M | 0.76% |
| 28 | ACADIA PHARMACEUTICALS INC | ACAD | 185,835 | $3.0M | 0.68% |
| 29 | CATALENT INC | 148806102 | 55,000 | $2.5M | 0.57% |
| 30 | VIR BIOTECHNOLOGY INC | VIR | 89,808 | $2.3M | 0.52% |
| 31 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 45,520 | $2.1M | 0.48% |